Viridian Therapeutics Inc VRDN Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	435.09M	386.64M	351.47M	328.76M	490.42M	630.38M	585.66M	771.9M
Total Current Assets	431.17M	382.6M	346.33M	323.84M	486.48M	626.82M	581.66M	767.36M
Cash and Equivalents	155.58M	88.52M	87.08M	111.6M	102.83M	91.64M	107.67M	200.32M
Total Non-Current Assets	5.24M	4.04M	5.14M	4.92M	5.62M	3.56M	4M	4.54M
Total Liabilities	40.03M	36.09M	35.61M	45.18M	48.4M	47.85M	56.33M	64.4M
Total Current Liabilities	33.35M	29.59M	28.66M	23.25M	26.64M	26.13M	36.76M	41.36M
Total Non-Current Liabilities	11.32M	11.18M	11.66M	41.93M	41.97M	42.05M	37.05M	43.56M
Common Equity	142.56M	135.34M	135.35M	135.35M	207.06M	200.35M	200.35M	189.68M
Retained Earnings	-488.17M	-556.33M	-611.39M	-659.05M	-725.91M	-774.45M	-839.44M	-916.13M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	4.26M	52.48M	66.15M	30.26M	131.26M	203.71M	435.09M	490.42M
Total Current Assets	4.26M	51.87M	65.37M	29.74M	129.61M	200.16M	431.17M	486.48M
Cash and Equivalents	3.34M	47.44M	32.61M	24.85M	45.9M	42.3M	155.58M	102.83M
Total Non-Current Assets	-326k	38.51M	51.34M	15.75M	-60.76M	187.72M	395.06M	442.02M
Total Liabilities	4.59M	13.97M	14.8M	14.51M	11.22M	15.99M	40.03M	48.4M
Total Current Liabilities	4.59M	3.9M	6.73M	10.18M	10.67M	13.64M	33.35M	26.64M
Total Non-Current Liabilities	0	20M	16.07M	8.66M	544k	2.36M	11.32M	41.97M
Total Equity	-326k	38.51M	51.34M	15.75M	-60.76M	187.72M	395.06M	442.02M
Common Equity	7k	226k	308k	349k	42k	134.07M	142.56M	207.06M
Retained Earnings	-30.64M	-93.59M	-126.3M	-168.17M	-278.89M	-358.3M	-488.17M	-725.91M